| Literature DB >> 36233732 |
Ah Ran Oh1, Jungchan Park1,2, Jong-Hwan Lee1, Dan-Cheong Choi1, Kwangmo Yang2,3, Jin-Ho Choi4, Joonghyun Ahn5, Ji Dong Sung6, Seunghwa Lee6,7.
Abstract
BACKGROUND: The sequential organ failure assessment (SOFA) score has been validated in various clinical situations. However, it has not been investigated during a short stay in the intensive care unit (ICU). This study aimed to evaluate the association between the SOFA score and outcomes in patients who were monitored for less than one day after non-cardiac surgery.Entities:
Keywords: intensive care units; mortality; non-cardiac surgery; sequential organ failure assessment score
Year: 2022 PMID: 36233732 PMCID: PMC9573186 DOI: 10.3390/jcm11195865
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.964
Baseline characteristics and outcomes according to quartile values of SOFA score immediately after surgery.
| 1st Quartile = 0 | 2nd Quartile = 1 | 3rd Quartile = 2 | 4th Quartile ≥ 3 | |
|---|---|---|---|---|
| Immediate SOFA score | 0 (0–0) | 1 (1–1) | 2 (2–2) | 4 (3–5) |
| Follow-up SOFA score | 0 (0–0) | 0 (0–0) | 1 (0–1) | 1 (0–2) |
| ICU stay, hours | 19.6 (±3.0) | 19.6 (±3.0) | 19.5 (±3.1) | 19.0 (±3.3) |
| Preoperative ICU | 34 (0.7) | 17 (0.3) | 17 (0.5) | 47 (1.3) |
| Scheduled ICU admission | 3774 (73.1) | 2723 (51.5) | 2163 (59.7) | 2984 (82.0) |
| Male | 2345 (45.4) | 2904 (54.9) | 2160 (59.6) | 2442 (67.1) |
| Age | 55.1 (±14.1) | 58.8 (±12.8) | 60.7 (±12.0) | 62.7 (±12.7) |
| Hypertension | 1456 (28.2) | 1738 (32.9) | 1393 (38.4) | 1597 (43.9) |
| Diabetes | 684 (13.2) | 822 (15.6) | 714 (19.7) | 841 (23.1) |
| Current alcohol | 1114 (21.6) | 928 (17.6) | 642 (17.7) | 613 (16.8) |
| Current smoking | 493 (9.5) | 336 (6.4) | 277 (7.6) | 272 (7.5) |
| Chronic kidney disease | 17 (0.3) | 336 (6.4) | 277 (7.6) | 272 (7.5) |
| Dialysis | 0 | 1 (0.0) | 3 (0.1) | 67 (1.8) |
| Previous disease | ||||
| Charlson comorbidity index | 0.26 (±0.66) | 0.29 (±0.75) | 0.35 (±0.85) | 0.53 (±1.19) |
| Stroke | 181 (3.5) | 194 (3.7) | 152 (4.2) | 225 (6.2) |
| Coronary artery disease | 165 (3.2) | 186 (3.5) | 140 (3.9) | 215(5.9) |
| Heart failure | 18 (0.3) | 22 (0.4) | 25 (0.7) | 75 (2.1) |
| Arrhythmia | 87 (1.7) | 139 (2.6) | 100 (2.8) | 164 (4.5) |
| Peripheral artery disease | 68 (1.3) | 61 (1.2) | 39 (1.1) | 63 (1.7) |
| Aortic disease | 39 (0.8) | 44 (0.8) | 50 (1.4) | 119 (3.3) |
| Valvular heart disease | 5 (0.1) | 13 (0.2) | 7 (0.2) | 16 (0.4) |
| Chronic obstructive pulmonary disease | 131 (2.5) | 213 (4.0) | 193 (5.3) | 200 (5.5) |
| Operative variables | ||||
| Intermediate-to-high surgical risk | 5019 (97.2) | 5163 (97.7) | 3530 (97.4) | 3424 (94.1) |
| General anesthesia | 5147 (99.7) | 5274 (99.8) | 3611 (99.6) | 3605 (99.1) |
| Emergency operation | 335 (6.5) | 247 (4.7) | 181 (5.0) | 356 (9.8) |
| Operation duration, min | 194 (±106) | 190 (±100) | 211 (±118) | 242 (±133) |
| Operation type | ||||
| Neuroendocrine | 31 (0.6) | 23 (0.4) | 16 (0.4) | 24 (0.7) |
| Lung | 1148 (22.2) | 2395 (45.3) | 1400 (38.6) | 725 (19.9) |
| Head and Neck | 2509 (48.6) | 1429 (27.0) | 782 (21.6) | 608 (16.7) |
| Breast | 11 (0.2) | 10 (0.2) | 5 (0.1) | 1 (0.0) |
| Stomach | 170 (3.3) | 120 (2.3) | 94 (2.6) | 132 (3.6) |
| Hepatobiliary | 441 (8.5) | 456 (8.6) | 680 (18.8) | 940 (25.8) |
| Colorectal | 242 (4.7) | 189 (3.6) | 148 (4.1) | 257 (7.1) |
| Urology | 46 (0.9) | 60 (1.1) | 58 (1.6) | 112 (3.1) |
| Gynecology | 39 (0.8) | 37 (0.7) | 39 (1.1) | 45 (1.2) |
| Bone and Skin, etc. | 526 (10.2) | 567 (10.7) | 404 (11.1) | 795 (21.8) |
| Outcomes | ||||
| 3-year mortality | 603 (11.7) | 622 (11.8) | 548 (15.1) | 648 (17.8) |
| 1-year mortality | 256 (5.0) | 265 (5.0) | 240 (6.6) | 335 (9.2) |
| 30-day mortality | 8 (0.2) | 14 (0.3) | 17 (0.5) | 46 (1.3) |
| PACE | 362 (7.0) | 484 (9.2) | 374 (10.3) | 522 (14.3) |
| PPC | 808 (15.6) | 1133 (21.4) | 933 (25.7) | 1120 (30.8) |
| Acute kidney injury, any | 96 (1.5) | 150 (2.8) | 142 (3.9) | 380 (10.4) |
| Stage 1 | 63 (1.2) | 139 (2.6) | 126 (3.5) | 306 (8.4) |
| Stage 2 | 10 (0.2) | 7 (0.1) | 14 (0.4) | 44 (1.2) |
| Stage 3 | 3 (0.1) | 4 (0.1) | 2 (0.1) | 30 (0.8) |
Data are presented as n (%), mean (±standard deviation), or median (interquartile). Surgical risk was stratified according to 2014 European Society of Cardiology/European Society of Anaesthesiology guidelines. SOFA, sequential organ failure assessment; ICU, intensive care unit; PACE, perioperative adverse cardiac events; PPC, postoperative pulmonary complication.
Baseline characteristics according to SOFA score change during short ICU stay.
| Stable SOFA | Worsened SOFA | ASD before IPW | ASD after IPW | ||
|---|---|---|---|---|---|
| Immediate SOFA score | 1 (0-2) | 1 (0-2) | <0.001 | 35.5 | |
| Follow-up SOFA score | 0 (0-1) | 3 (1-3) | <0.001 | >99 | |
| ICU stay, hours | 19.5 (±3.1) | 19.5 (±3.3) | 0.56 | 1.5 | 1.6 |
| Preoperative ICU | 17 (1.1) | 98 (0.6) | 0.03 | 5.4 | 2.3 |
| Scheduled ICU admission | 928 (60.3) | 10716 (66.2) | <0.001 | 12.3 | 0.9 |
| Male | 8886 (54.9) | 965 (62.7) | <0.001 | 15.9 | 0.7 |
| Age | 58.6 (±13.4) | 62.0 (±12.7) | <0.001 | 26.7 | 0.6 |
| Hypertension | 5599 (34.6) | 585 (38.0) | 0.01 | 7.1 | 0.2 |
| Diabetes | 2739 (16.9) | 322 (20.9) | <0.001 | 10.2 | <0.01 |
| Current alcohol | 3034 (18.8) | 263 (17.1) | 0.12 | 4.3 | 1.4 |
| Current smoking | 1248 (7.7) | 130 (8.5) | 0.33 | 2.7 | 0.8 |
| Chronic kidney disease | 310 (1.9) | 46 (3.0) | <0.001 | 6.9 | 0.4 |
| Dialysis | 67 (0.4) | 4 (0.3) | 0.48 | 2.7 | 3.2 |
| Previous disease | |||||
| Charlson comorbidity index | 0.34 (±0.85) | 0.42 (±1.00) | <0.001 | 9.5 | 5.4 |
| Stroke | 669 (4.1) | 83 (5.4) | 0.02 | 5.9 | 0.7 |
| Coronary artery disease | 642 (4.0) | 64 (4.2) | 0.76 | 1 | 0.3 |
| Heart failure | 124 (0.8) | 16 (1.0) | 0.31 | 2.9 | 1.9 |
| Arrhythmia | 425 (2.6) | 65 (4.2) | <0.001 | 8.8 | 0.2 |
| Peripheral artery disease | 192 (1.2) | 39 (2.5) | <0.001 | 10 | 0.1 |
| Aortic disease | 211 (1.3) | 41 (2.7) | <0.001 | 9.8 | 0.9 |
| Valvular heart disease | 39 (0.2) | 2 (0.1) | 0.56 | 2.6 | 0.7 |
| Chronic obstructive pulmonary disease | 666 (4.1) | 71 (4.6) | 0.38 | 2.4 | 0.5 |
| Operative variables | |||||
| Intermediate-to-high surgical risk | 15,632 (96.6) | 1504 (97.8) | 0.02 | 7 | 0.9 |
| General anesthesia | 16,110 (99.6) | 1527 (99.3) | 0.12 | 4.1 | 1.4 |
| Emergency operation | 1005 (6.2) | 114 (7.4) | 0.07 | 4.8 | 0.3 |
| Operation duration, min | 206 (±115) | 209 (±110) | 0.36 | 2.5 | 1.1 |
| Operation type | <0.001 | 34.3 | 24.4 | ||
| Neuroendocrine | 86 (0.5) | 8 (0.5) | |||
| Lung | 5116 (31.6) | 552 (35.9) | |||
| Head and Neck | 5055 (31.2) | 273 (17.8) | |||
| Breast | 26 (0.2) | 1 (0.1) | |||
| Stomach | 481 (3.0) | 35 (2.3) | |||
| Hepatobiliary | 2213 (13.7) | 304 (19.8) | |||
| Colorectal | 761 (4.7) | 75 (4.9) | |||
| Urology | 252 (1.6) | 24 (1.6) | |||
| Gynecology | 144 (0.9) | 16 (1.0) | |||
| Bone and Skin, etc. | 2042 (12.6) | 250 (16.3) |
Data are presented as n (%), mean (±standard deviation), or median (interquartile). Surgical risk was stratified according to 2014 European Society of Cardiology/European Society of Anaesthesiology guidelines. SOFA, sequential organ failure assessment; ICU, intensive care unit; ASD, absolute standardized mean difference; IPW, inverse probability weighting.
Mortalities according to perioperative adverse cardiac event (PACE).
| Stable SOFA | Worsened SOFA | Unadjusted HR or OR (95% CI) | Adjusted HR or OR | IPW Adjusted HR or OR (95% CI) | ||||
|---|---|---|---|---|---|---|---|---|
| 3-year mortality | 2135 (13.2) | 286 (18.6) | 1.42 (1.26–1.61) | <0.001 | 1.32 (1.16–1.49) | <0.001 | 1.26 (1.10–1.43) | <0.001 |
| 1-year mortality | 955 (5.9) | 141 (9.2) | 1.57 (1.32–1.88) | <0.001 | 1.45 (1.22–1.73) | <0.001 | 1.38 (1.15–1.66) | <0.001 |
| 30-day mortality | 70 (0.4) | 15 (1.0) | 2.26 (1.29–3.95) | 0.004 | 2.11 (1.20–3.69) | 0.01 | 1.88 (1.05–3.37) | 0.034 |
| PACE * | 1533 (9.5) | 209 (13.6) | 1.50 (1.28–1.75) | <0.001 | 1.28 (1.09–1.50) | <0.001 | 1.23 (1.04–1.45) | <0.001 |
| PPC * | 3578 (22.1) | 416 (27.0) | 1.31 (1.59–1.47) | <0.001 | 1.22 (1.08–1.38) | <0.001 | 1.26 (1.12–1.42) | <0.001 |
| Acute kidney injury, any * | 608 (3.8) | 140 (9.1) | 2.56 (2.11–3.10) | <0.001 | 2.25 (1.84–2.72) | <0.001 | 2.13 (1.73–2.60) | <0.001 |
| Stage 1 | 517 (3.2) | 117 (7.6) | ||||||
| Stage 2 | 62 (0.4) | 13 (0.8) | ||||||
| Stage 3 | 29 (0.2) | 10 (0.7) |
Data are presented as n (%). The multivariable analysis retained male, age, diabetes, and peripheral arterial occlusive disease. IPW adjustment retained all relevant variables. Risk of mortality was presented as HR and the other outcomes * are presented with OR. HR, hazard ratio; OR, odds ratio; CI, confidence interval; IPW, inverse probability weighting; PACE, perioperative adverse cardiac events; PPC, postoperative pulmonary complication.
Figure 1Kaplan–Meier curves for (A) three-year mortality and (B) one-year mortality.
Figure 2The Shapley additive explanations (SHAP) summary plot representing the results of the extreme gradient boosting (XGB) algorithm of machine learning technique.